spacer
home > ict > winter 2019 > redefining the gold standard
PUBLICATIONS
International Clinical Trials

Redefining the Gold Standard

Adaptive clinical trials have risen in popularity and gained more attention since the FDA Critical Path Initiative (2004) and Critical Path Opportunity List (2006) called for innovative solutions to transform the way medicinal products are developed, evaluated, and manufactured. They are now being commonly used to quickly predict the likelihood of the success or failure of a drug in early stages of drug development.

The release of the FDA’s draft guidance in 2010 on “adaptive design clinical trials for drugs and biologics” provided a suggested framework for designing such studies and for using them to make decisions that would allow the innovator to “fail early.” EMA’s Committee for Medicinal Products for Human Use released a similar draft in 2006 (1).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Chitra Lele is Chief Scientific Officer at Sciformix, a Covance Company, with over 20 years of experience in the healthcare industry. She has been part of the company’s leadership from its inception and has been instrumental in establishing and growing the organisation. Prior to Sciformix, Chitra was Executive Director responsible for Indian operations of Pfizer Global R&D. With a PhD in statistics from Stanford University, US, her prior experience includes work as a biostatistician in cancer epidemiology at both Stanford and University of California, US.

Dr Ritu Budania is a Drug Safety Physician for global medical safety operations at Sciformix, a Covance Company. She completed her MBBS from Topiwala National Medical College, India, and MD Pharmacology from Government Medical College, India. Ritu has assisted in preparing ‘Desk View Clinical Trials in India’ for the WHO and prepared signal reports for Pharmacovigilance Programme of India (PvPI). She was in charge of the adverse drug monitoring centre under PvPI, at King Edward Memorial Hospital, India. Ritu has expertise in pharmacovigilance, clinical pharmacology, medical writing, clinical research, and clinical trials. She is also an experienced industry guest speaker in the subject of pharmacology.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Kallik’s Release 6 sets new benchmarks for speed, accuracy and efficiency

Tamworth, UK – 15 June 2019 – Global provider of labelling and artwork management solutions, Kallik, is launching an update to its AMS360 solution – its Release 6, transforming the experience of the business user, whilst defining new benchmarks for speed, accuracy, and efficiency of global labelling and artwork processes.
More info >>

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

 
Industry Events

SCOPE Europe – Summit for Clinical Ops Executives Europe

17-18 September 2019, Barcelona, Spain

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement